J Virol. 1990 August; 64(8): 3716-3725
Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
R M Stephens,
D Derse and
N R Rice
Laboratory of Molecular Virology and Carcinogenesis, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21701.
ABSTRACT
We isolated and characterized six cDNA clones from an equine infectious anemia virus-infected cell line that displays a Rev-defective phenotype. With the exception of one splice site in one of the clones, all six cDNAs exhibited the same splicing pattern and consisted of four exons. Exon 1 contained the 5' end of the genome; exon 2 contained the tat gene from mid-genome; exon 3 consisted of a small section of env, near the 5' end of the env gene; and exon 4 contained the putative rev open reading frame from the 3' end of the genome. The structures of the cDNAs predict a bicistronic message in which Tat is encoded by exons 1 and 2 and the presumptive Rev protein is encoded by exons 3 and 4. tat translation appears to be initiated at a non-AUG codon within the first 15 codons of exon 1. Equine infectious anemia virus-specific tat activity was expressed in transient transfections with cDNA expression plasmids. The predicted wild-type Rev protein contains 30 env-derived amino acids and 135 rev open reading frame residues. All of the cDNAs had a frameshift in exon 4, leading to a truncated protein and thus providing a plausible explanation for the Rev-defective phenotype of the original cells. We used peptide antisera to detect the faulty protein, thus confirming the cDNA sequence, and to detect the normal protein in productively infected cells.
J Virol. 1990 August; 64(8): 3716-3725
This article has been cited by other articles:
-
Ohnishi, T., Muroi, M., Tanamoto, K.-i.
(2003). MD-2 Is Necessary for the Toll-Like Receptor 4 Protein To Undergo Glycosylation Essential for Its Translocation to the Cell Surface. CVI
10: 405-410
[Abstract]
[Full Text]
-
McGuire, T. C., Leib, S. R., Lonning, S. M., Zhang, W., Byrne, K. M., Mealey, R. H.
(2000). Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J. Gen. Virol.
81: 2735-2739
[Abstract]
[Full Text]
-
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., Cullen, B. R.
(1999). Highly Divergent Lentiviral Tat Proteins Activate Viral Gene Expression by a Common Mechanism. Mol. Cell. Biol.
19: 4592-4599
[Abstract]
[Full Text]
-
Otero, G. C., Harris, M. E., Donello, J. E., Hope, T. J.
(1998). Leptomycin B Inhibits Equine Infectious Anemia Virus Rev and Feline Immunodeficiency Virus Rev Function but Not the Function of the Hepatitis B Virus Posttranscriptional Regulatory Element. J. Virol.
72: 7593-7597
[Abstract]
[Full Text]
-
Harris, M. E., Gontarek, R. R., Derse, D., Hope, T. J.
(1998). Differential Requirements for Alternative Splicing and Nuclear Export Functions of Equine Infectious Anemia Virus Rev Protein. Mol. Cell. Biol.
18: 3889-3899
[Abstract]
[Full Text]
-
Belshan, M., Harris, M. E., Shoemaker, A. E., Hope, T. J., Carpenter, S.
(1998). Biological Characterization of Rev Variation in Equine Infectious Anemia Virus. J. Virol.
72: 4421-4426
[Abstract]
[Full Text]
-
Cook, R. F., Leroux, C., Cook, S. J., Berger, S. L., Lichtenstein, D. L., Ghabrial, N. N., Montelaro, R. C., Issel, C. J.
(1998). Development and Characterization of an In Vivo Pathogenic Molecular Clone of Equine Infectious Anemia Virus. J. Virol.
72: 1383-1393
[Abstract]
[Full Text]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.